# US 2016/0354324 A1 · Method of Inhibiting Chronification of Pain

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354324 A1
- Document ID: US20160354324A1
- Status: Published application
- Kind: A1
- Application number: 15/243,271
- Filed: 2016-08-22
- Published: 2016-12-08
- Earliest claimed: 2011-04-05
- Assignees: Gruenenthal GmbH
- Applicants: Gruenenthal GmbH
- Inventors: Klaus SCHIENE; Ilona STEIGERWALD; Michel HAMON; Johannes SCHNEIDER; Silvia REINARTZ; Ulrich JAHNEL; Thomas TZSCHENTKE
- Web page: https://patentgrep.com/patent/US20160354324A1

## CPC

- A61K 31/137: Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine {or methadone}
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 19/00: Drugs for skeletal disorders
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/06: Antimigraine agents
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61P 25/04: Centrally acting analgesics, e.g. opioids
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The use of tapentadol in the treatment of pain and/or pain chronification in a subject suffering from pain chronification and/or in the treatment of pain and inhibition of pain chronification in a subject suffering from pain and at risk of pain chronification, as well as the use of tapentadol for the treatment or inhibition of migraine.

## Claims

### Claim 1

A method of treating pain in a subject suffering from pain chronification or for inhibiting pain chronification in a subject suffering from pain and at risk for pain chronification, said method comprising administering to said subject an effective pain alleviating or pain chronification inhibiting amount of tapentadol.

### Claim 2 (depends on 1)

A method as recited in claim 1, wherein said subject is a subject suffering from pain and at risk of pain chronification, and the tapentadol is administered in an effective pain alleviating and pain chronification inhibiting amount.

### Claim 3 (depends on 1)

A method as recited in claim 1, wherein said subject is a subject suffering from pain and pain chronification, and the tapentadol is administered in an effective pain alleviating and pain chronification treating amount.

### Claim 4 (depends on 1)

A method as recited in claim 1, wherein said subject is a subject suffering from pain, and the tapentadol is administered in an effective pain alleviating amount.

### Claim 5 (depends on 1)

A method as recited in claim 1, wherein said subject is a subject suffering from central pain.

### Claim 6 (depends on 1)

A method as recited in claim 1, wherein said subject is a subject suffering from peripheral pain.

### Claim 7 (depends on 1)

A method as recited in claim 1, wherein said subject is a subject suffering from acute pain.

### Claim 8 (depends on 7)

A method as recited in claim 7, wherein said acute pain is selected from the group consisting of mechanical pain, heat pain, cold pain, ischemic pain, and chemical-induced pain.

### Claim 9 (depends on 1)

A method as recited in claim 1, wherein said subject is a subject suffering from pain selected from the group consisting of postoperative pain, inflammatory pain, migraine-pain, headache pain, irritable bowel syndrome pain, fibromyalgia pain, arthritic pain, skeletal pain, joint pain, gastrointestinal pain, muscle pain, angina pain, facial pain, pelvic pain, claudication, postoperative pain, post traumatic pain, tension headache pain, obstetric pain, gynecological pain, and chemotherapy-induced pain.

### Claim 10 (depends on 1)

A method as recited in claim 1, wherein said subject is a subject suffering from postoperative pain and the tapentadol is administered:
during N1 consecutive days of a postoperative phase P1,
during N2 consecutive days of a phase P2 following said postoperative phase P1,
but not during N3 consecutive days of a phase P3 following said phase P2;
wherein N1, N2 and N3 each independently denote an integer of from 1 to 100, with the proviso that N1≧N2.

### Claim 11 (depends on 10)

A method as recited in claim 10, wherein N3≧N1≧N2 or N3≧N2≧N1.

### Claim 12

A method of treating or inhibiting migraine in a subject suffering therefrom, said method comprising administering to said subject an effective migraine treating or inhibiting amount of tapentadol.

### Claim 13 (depends on 1)

A method as recited in claim 1, wherein said subject is a subject suffering from moderate or severe pain.

### Claim 14 (depends on 1)

A method as recited in claim 1, wherein the tapentadol is administered orally.

### Claim 15 (depends on 1)

A method as recited in claim 1, wherein the tapentadol is administered one daily.

### Claim 16 (depends on 1)

A method as recited in claim 1, wherein the tapentadol is administered twice daily.

### Claim 17 (depends on 1)

A method as claimed in claim 1, wherein the tapentadol is administered at a daily dose within the range of from 25 to 600 mg.
